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Straining for Perfection*
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The hunt for optimal approaches to assessment of myocar-
dial performance has been longstanding. However, assess-
ment of segmental myocardial function lagged for decades
and was largely qualitative and subjective, on the basis of
endocardial excursion or wall thickening, not quantitative
myocardial deformation. As the era of revascularization
began, the need for better assessment of segmental myocar-
dial function stood out. In experimental models, it was
simple: implanted sonomicrometry crystal pairs and arrays
could depict segmental deformation. In humans, it was
more challenging. Ultimately, in the late 1980s, cardiac
magnetic resonance (CMR) with saturation band tissue
tagging emerged, first at Johns Hopkins, then at the University
of Pennsylvania, enabling evaluation of segmental deformation
of the myocardium noninvasively in humans (1,2). Research
applications emerged rapidly, as did more advanced
2-dimensional and 3-dimensional analytic approaches (3–6).
See page 1140
However, limited availability of CMR, the need for both
conventional cine and tagged imaging in each patient,
limited temporal resolution, and lengthy post-processing
made real clinical applications impractical. In the late 1990s,
tissue Doppler and then speckle tracking led to rediscovery
of strain by echocardiologists, making clinical applications
feasible. But despite the wide availability of echocardiogra-
phy, progress toward wide clinical adoption has been
relatively slow. The first obvious target, assessment of
asynchrony and biventricular pacing, has proved more chal-
lenging and the results more controversial than anticipated.
The limited reproducibility, angle dependence, and limited
transthoracic sampling that complicate tissue Doppler have
been part of the problem. Speckle tracking avoids some of
these limitations, but creates additional challenges. Given
the limitations of both CMR and echocardiographic strain
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disclose.and strain rate imaging, a skeptic might conclude that, like
too many other innovations in cardiac imaging, these are
not destined for prime time. However, mastery of technical
challenges takes time, and the drive to achieve practical,
high-impact clinical tools based on strain and strain rate
imaging is far from over.
In this issue of the Journal, Korosoglou et al. (7) from
Heidelberg, Germany, using methods developed at Johns
Hopkins, report striking data demonstrating that CMR
dobutamine stress with strain and strain rate imaging
provides improved detection of coronary stenoses, with an
increase from 84% to 96% in sensitivity without loss of
specificity and improved long-term risk stratification of
patients, with an increase in chi-square from 39.3 for
combined clinical variables and wall motion abnormalities
to 50.7 for segmental strain maps and 52.5 for segmental
strain rate reserve (both p  0.001). This is actually the
third paper in a series that previously demonstrated both
detection of ischemia at lower dobutamine doses and
improved diagnostic performance with CMR strain and
strain rate imaging. They conclude appropriately that
“Strain-encoded MRI aids the accurate identification of
patients at high risk for future cardiac events and revascu-
larization procedures, beyond the assessment of conven-
tional atherogenic risk factors and resting or inducible [wall
motion abnormality] on cine images.” As important, the
imaging technique used, strain-encoded magnetic resonance
imaging (SENC), permits rapid, objective, and operator-
independent image post-processing methods, and key prog-
nostic information is immediately available as color maps.
Thus, the approach is suitable for widespread clinical use
where expert CMR is available. Regrettably, while the
impact of this approach will be high in many European
centers, slow diffusion of CMR into routine practice in the
United States, where it is entrapped in turf battles and
economic pressures, is likely to limit access to these very
promising methods to a handful of academic centers.
Nonetheless, this report dramatically advances CMR strain
imaging with stress and clearly demonstrates substantial
potential clinical value. The results appear to be more robust
than those currently available for echocardiographic strain
imaging with stress, whether using tissue Doppler or speckle
tracking techniques. While further prospective testing in
larger and more diverse multicenter studies is highly desir-
able, the basic response to this study should certainly be
“point proven.”
It has been a long time coming. The paucity of real
clinical applications for CMR tissue tagging20 years after
its emergence has been due in part to technical challenges,
but also to hesitancy by industry to devote substantial
resources to the challenges of CMR given the initial modest
size of the market for CMR imaging and post-processing
software. The contribution of the turf wars between radiol-
ogy and cardiology in the United States and elsewhere over
CMR to the slow development of the field cannot be
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needed to advance the field has often been rooted in the
proprietary domains of major technology corporations, Na-
tional Institutes of Health funding mechanisms may not
have contributed as much to advancement of the field as
would have been desirable. Nonetheless, even the earliest
studies of segmental myocardial deformation during pro-
gressive dobutamine infusion in normal humans offered
intriguing insights (8), leading almost linearly to the current
report (7).
Those early data pointed to the fact that circumferential
shortening became maximal at very low doses of dobut-
amine, even before heart rate acceleration, suggesting that
absolute strain would not be the ideal parameter for assess-
ment of contractile state. In contrast, strain rate showed a
linear relationship to dobutamine dose and, presumably,
inotropic state over a wider range of dobutamine dose and
heart rate. Such observations resonated with the wide
recognition in the 1990s that imaging stress testing, despite
2 decades of development, was still not performing
optimally, particularly in women. These factors set the stage
for further efforts to make CMR strain analysis fast enough
for use during stress testing. It took the emergence, from the
academic world rather than industry, of the next major
advance in CMR strain imaging and post-processing: har-
monic phase MRI (HARP): HARP shortened data reduc-
tion and analysis time by a factor of 10, compared favorably
for quantitation of strain with conventional tag analysis, and
also demonstrated sensitivity to provocable ischemia in
animal models (9). Evidence from animal models of provo-
cable ischemia and myocardial viability then reconfirmed
the longstanding expectation that strain analysis was more
sensitive than conventional wall motion analysis in detection
of impaired myocardial perfusion reserve. The emergence of
new variants on tissue tagging such as SENC has also
created new opportunities to advance the field.
Where do we go from here? Technical development
continues. A promising alternative to tagging, CMR
DENSE (displacement encoding with stimulated echos)
imaging, may permit more progress. Echo speckle tracking
has been adapted to conventional CMR cine images as
“feature tracking” and gives results similar to those of
HARP while eliminating the need for additional imaging.
Ongoing market-driven advances in the echocardiography
software will spill over to CMR, offering faster analysis andbetter visual displays. In addition, competition between
echocardiography and CMR will continue. More definitive
large-scale multicenter trials using both technologies are
needed to evaluate their relative utility and cost effective-
ness. Lastly, economic pressures in healthcare threaten to
prevent wide clinical application of advanced echocardiog-
raphy and, especially, CMR strain methods unless large,
compelling multicenter trials showing clinical and cost
effectiveness can persuade the health policy and Center for
Medicare Services constituencies of real value. Perfection of
strain imaging will not come easily. But then, to borrow a
famous phrase, cardiac imaging ain’t for sissies.
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